Menu

• Ask a Health Expert about OVARIAN FAILURE
• Post Your Side Effect related to OVARIAN FAILURE
• OVARIAN FAILURE and FDA Warnings
• OVARIAN FAILURE in Patients Wiki
• Report OVARIAN FAILURE in Drug Side Effect Survey

OVARIAN FAILURE side effect

What is OVARIAN FAILURE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Etoposide Side Effects Report #5676111-X
Consumer or non-health professional from BRAZIL reported ETOPOSIDE problem on Mar 13, 2008. Female patient, 26 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, ovarian failure, pulmonary embolism, . ETOPOSIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, BLEOMYCIN SULPHATE, CYTARABINE, VINCRISTINE, PREDNISONE, CARMUSTINE, MELPHALAN. Patient recovered.

Doxorubicin Side Effects Report #5695031-8
DOXORUBICIN problem was reported by a Consumer or non-health professional from BRAZIL on Mar 25, 2008. Female patient, 26 years of age, was diagnosed with hodgkin's disease and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, ovarian failure, pulmonary embolism, . DOXORUBICIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE, BLEOMYCIN SULPHATE. Patient recovered.

Humatrope Side Effects Report #5256653-1
Physician from UNITED STATES reported HUMATROPE problem on Feb 21, 2007. Female patient, 13 years of age, weighting 118.8 lb, was diagnosed with turner's syndrome and was treated with HUMATROPE. After drug was administered, patient experienced the following problems/side effects: epiphysiolysis, ovarian failure, . HUMATROPE dosage: 0.375 MG/KG, WEEKLY (1/W). Patient recovered.

Humatrope Side Effects Report #5256662-2
HUMATROPE problem was reported by a Physician from UNITED STATES on Feb 21, 2007. Female patient, 13 years of age, weighting 119.9 lb, was diagnosed with turner's syndrome and was treated with HUMATROPE. After drug was administered, patient experienced the following problems/side effects: epiphysiolysis, ovarian failure, . HUMATROPE dosage: 0.375 MG/KG, WEEKLY (1/W). Patient recovered.


Cyclophosphamide Side Effects Report #5554439-1
Health Professional from GREECE reported CYCLOPHOSPHAMIDE problem on Dec 10, 2007. Female patient, 28 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, hormone level abnormal, ovarian failure, uterine haemorrhage, vaginal disorder, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOSPORINE. Patient recovered.